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Background: An important element in achieving high success rates with free flap surgery has been the use of different techniques for mon-
itoring flaps postoperatively as a means to detecting vascular compromise. Successful monitoring of the vascular pedicle to a flap can
potentiate rapid return to theater in the setting of compromise, with the potential to salvage the flap. There is little evidence that any tech-
nique offers any advantage over clinical monitoring alone. Methods: A consecutive series of 547 patients from a single plastic surgical unit
who underwent a fasciocutaneous free flap operation for breast reconstruction [deep inferior epigastric artery perforator (DIEP) flap, super-
ficial inferior epigastric artery (SIEA) flap, or superior gluteal artery perforator (SGAP) flap] were included. A comparison was made
between the first 426 consecutive patients in whom flap monitoring was performed using clinical monitoring alone and the subsequent 121
patients in whom monitoring was achieved with the Cook-Swartz implantable Doppler probe. Outcome measures included flap salvage
rate and false-positive rate. Results: There was a strong trend toward improved salvage rates with the implantable Doppler probe com-
pared with clinical monitoring (80% vs. 66%, P 5 0.48). When combined with the literature (meta-analysis), the data prove statistically sig-
nificant (P < 0.01). There was no statistical difference between the groups for false-positive rates. Conclusion: Flap monitoring with the
implantable Doppler probe can improve flap salvage rates without increasing the rate of false-positive takebacks. VC 2009 Wiley-Liss, Inc.
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Success rates of free flap operations have steadily
increased since their inception four decades ago. An im-
portant element in achieving these outcomes has been the
use of different techniques for monitoring flaps postoper-
atively as a means to detecting vascular compromise.
Successful monitoring of the vascular pedicle to a flap
can potentiate rapid return to theater in the setting of
compromise, with the potential to salvage the flap.
There is universal agreement that early intervention is
key to the successful salvage of a flap that has become
compromised by arterial or venous thrombosis, external
compression, or kinking of the pedicle.1–6 Currently, the
only method that is ubiquitous amongst microsurgical
units is the use of clinical monitoring.7,8 Although some
studies have demonstrated that adjunctive monitoring
techniques may have benefit, and indeed that flap salvage
rate may be increased,9–11 there are still no large-scale
comparative trials supporting these studies. Without rea-
sonable evidence for new monitoring techniques, bedside
monitoring has remained the norm, with some units using
adjunctive techniques at the discretion of the surgeon.7,8
The implantable Doppler probe manufactured by
Cook1 has been the subject of several recent articles in
the plastic surgery literature.10,12–20 Despite these recent
publications, only one previous study assessing the
implanted Doppler probe has used clinically relevant end-
points as its primary outcome measure.10 This study was
thus undertaken to assess the surgical outcomes associ-
ated with the Cook-Swartz probe on large scale, in a way
that enables objective evaluation of its efficacy.
METHODS
A retrospective analysis of a consecutive series of
patients from a single plastic surgical unit was undertaken.
All patients who underwent a fasciocutaneous free flap
operation for breast reconstruction [deep inferior epigastric
artery perforator (DIEP) flap, superficial inferior epigastric
artery (SIEA) flap, or superior gluteal artery perforator
(SGAP) flap] were included. All the patients were moni-
tored postoperatively with only one of clinical monitoring
alone or with the Cook-Swartz implantable Doppler probe.
The analysis was achieved by chart review.
Patient records were assessed to determine the postop-
erative course after their free flap operation. Several fac-
tors were identified for each patient, including whether
they were taken back to theater for presumed pedicle
compromise, reoperative findings, and final outcomes of
their operations.
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Application of Clinical Monitoring
Clinical monitoring was achieved through the assess-
ment of the color, temperature, tactility, capillary refill,
bleeding, and appearance of the flap. Assessment begins
intraoperatively and is continued by both medical and
nursing staff postoperatively. Suspicion of flap compro-
mise by either nursing or more junior medical staff
results in consultation with senior medical staff who bear
the ultimate responsibility for decisions to reexplore the
flap.
Application of the Cook-Swartz Implantable
Doppler Probe
The Cook-Swartz probe (Cook Medical1, Cook Ire-
land Ltd, Limerick, Ireland) comes with a specifically
designed silicone cuff, which is wrapped carefully around
the venous pedicle following successful venous anastomo-
sis. Application is always distal to the anastomosis, and
our surgeons prefer to use microclips rather than sutures or
glue for attachment. The tension of the silicone cuff is im-
portant, as a tight cuff may cause venous outflow obstruc-
tion, while a loose cuff is prone to false-positive results.
Multiple venous anastomoses can be monitored simultane-
ously with the Cook-Swartz system. Routine flap monitor-
ing is performed without adjunctive clinical monitoring.
As such, we use Cook-Swartz probe as a primary monitor-
ing technique, with thorough clinical assessment following
any detection of pedicle compromise by the probe.
The Cook-Swartz probe is first used intraoperatively,
both to ensure proper application of the probe and to
check anastomotic patency during flap insetting. Any
problems detected intraoperatively can then be reexplored
immediately. After completion of the operation, monitor-
ing surveillance using the probe is carried out by both
medical and nursing staff, who are instructed to report
any change in the audible output to medical staff.
Algorithm and Outcome Analysis
Each flap was categorized into one of each of the two
monitoring groups and were then stratified further into
groups according to an algorithm based on monitoring
findings (see Figs. 1 and 2). A monitored flap was first
stratified according to whether there was a positive moni-
toring ‘‘alarm’’ (i.e., the monitoring test suggested that
there was pedicle compromise requiring a return to thea-
ter for pedicle revision). Of the positive alarms, the find-
Figure 1. Flow chart for the recording of outcomes for each flap monitored with clinical monitoring alone. Each flap being monitored is
recorded as either encountering a positive monitoring alarm or not encountering an alarm, with findings at theater noted, and ultimate out-
comes recorded for each group. [Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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ings at theater were then able to stratify these flaps into
those cases with confirmed pedicle compromise and those
without any pedicle compromise identified. In all the
groups, the final flap outcomes were then documented.
Two primary outcome measures were assessed. The
first was the flapsalvage rate, calculated as all flaps with
true pedicle compromise that ultimately survived divided
by all flaps with true pedicle compromise (i.e., all true
positives and all false negatives). The second was the
false-positive rate, which was calculated as all flaps with
positive monitoring alarms that were found to have no
pedicle compromise (i.e., false positives) divided by all
flaps with no pedicle compromise (i.e., all false positives
and all true negatives). These have been described previ-
ously as true tests of the efficacy of each technique by
Whitney et al.9 and Lineaweaver,21 with flap salvage rate
showing the benefit of any monitoring technique in
improving outcomes and the false-positive rate reporting
the number of needless returns to theater. Both of these
measures are aimed at demonstrating the effectiveness of
the monitoring technique when compared with no moni-
toring at all (or a nonfunctioning monitor, a concept that
is also of Lineaweaver’s invention21). It is clear that a
reasonable monitoring technique can perform well when
compared with a nonfunctioning monitor, but it is also
important that the new method is better than the clinical
standard. For this reason, it is important that any prospec-
tive monitoring technique is compared with clinical moni-
toring alone in the critical analysis of its effectiveness.
The false-negative rate was not included, as this calcu-
lation is dependent upon surgeon decision making; i.e., if
a flap is ultimately failing due to pedicle compromise (and
not salvaged), this case is recorded as reducing the flap
salvage rate of the given monitoring technique, regardless
of the decision to take a flap to theater for revision (which
would result in a true positive) or to not take it back to
theater (which would result in a false negative).
Data for each monitoring group was analyzed for sta-
tistical significance performed using Fisher’s exact test.
Statistical significance was considered at P  0.05.
RESULTS
The study comprised 547 consecutive patients. Of
these, a comparison was made between the first 426 con-
secutive patients in whom flap monitoring was performed
Figure 2. Flow chart for the recording of outcomes for each flap monitored with the Cook-Swartz implantable Doppler probe. Each flap
being monitored is recorded as either encountering a positive monitoring alarm or not encountering an alarm, with findings at theater
noted, and ultimate outcomes recorded for each group. [Color figure can be viewed in the online issue, which is available at www.
interscience.wiley.com.]
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using clinical monitoring alone and the subsequent 121
patients in whom monitoring was achieved with the
Cook-Swartz implantable Doppler probe. In terms of the
overall findings, 63 were taken back to theater, with all
but one flap demonstrating pedicle compromise (i.e., 62
true positives and 1 false positive). One flap not taken
back to theater ultimately failed (a false negative). Of the
63 flaps that did have pedicle compromise (62 of which
were true positives and 1 was a false negative), 43 were
salvaged (an overall flap salvage rate of 68%). Overall,
408 flaps out of the 426 ultimately survived (an overall
success rate of 96%).
Each flap was classified according to the algorithm
described, with a comparison between clinical monitoring
(Fig. 1) and the Cook-Swartz implantable Doppler probe
(Fig. 2). Table 1 summarizes operative and reoperative
outcomes. It can be seen that there were no differences
between the groups in term of overall salvage rates (98%
vs. 96%, P 5 0.18) and no statistically significant differ-
ences between the techniques in terms of the primary
outcome measures, flap salvage rate (80% vs. 66%, P 5
0.48), and false-positive rate (1% vs. 0%, P 5 0.23).
However, this trend toward increase flap salvage rate in
the implantable Doppler arm compared with clinical mon-
itoring alone (80% vs. 66%) was notable.
The primary outcome measures of efficacy (flap sal-
vage rate and false-positive rate) are calculated for each
group.
The use of the implantable Doppler probe was thus
able to potentiate the salvage of an additional 1.4 flaps
over the calculated salvage rate of clinical monitoring in
the same group.
DISCUSSION
There has been a substantial body of data presenting
anecdotal evidence for the use of a multitude of monitor-
ing techniques. However, there has been a relative pau-
city of trials that demonstrate the efficacy of any moni-
toring technique over clinical monitoring. To date, only
three such trials have been published, supporting the use
of quantitative fluorometry, laser Doppler flowmetry, and
the implanted Doppler probe.9–11
The first attempt to use an implantable Doppler probe
for free flap monitoring was in 1984 by Parker et al.,19
and soon afterward, Cook Medical developed a probe
specifically for use in free flap operations.20 It was ini-
tially used on the arterial pedicle, but subsequent studies
showed it to be more sensitive when placed on the ve-
nous anastomosis, particularly for the detection of venous
thrombosis.13 There have been some other minor revi-
sions in the technique used to apply the probe.
There is only one previous study that purports to
show that the implanted Doppler probe can improve flap
salvage rates.10 In this study, Kind et al. evaluated a se-
ries of 147 free flaps in 135 patients who were monitored
by this method. They reported an outstanding 100% flap
salvage rate, with a false-positive rate of 3.4%. Although
it is clear that these results weigh heavily in favor of the
implanted Doppler probe, the number of failing flaps in
this study was small. As such, further publication is nec-
essary for providing adequate evidence in support of the
use of implanted Doppler devices. We have previously
published a series of free flaps monitored with this
method,15 but this series was not compared with clinical
monitoring. By adding this comparative analysis to the
published literature, we hope to improve the evidence
supporting the use of the implanted Doppler probe.
Inclusive of the study by Kind et al., this is only the
second study to provide an objective comparison of the
implanted Doppler probe to clinical monitoring using
clinically relevant outcome measures as primary end-
points. A clear trend of increased flap salvage was seen
in our trial, but this trend was not statistically significant.
The groups were highly comparable, although the num-
bers in the Doppler arm were not as pronounced, and
with greater power to the study greater significance may
be achievable. Although the study by Kind et al. showed





Doppler probe P value
Raw data
True positives 52/426 5 12.2% 10/121 5 8.3% N/A
False positives 0/426 5 0% 1/121 5 0.8% N/A
True negatives 373/426 5 87.6% 110/121 5 90.9% N/A
False negatives 1/426 5 0.2% 0/121 5 0% N/A
Outcomes
Overall survival rate (n/%) 408/426 5 95.8% 119/121 5 98.3% 0.18
Flap salvage rate (salvaged flaps/compromised flaps) (n/%) 35/53 5 66% 8/10 5 80% 0.48
False-positive rate (false positives/uncompromised flaps) (n/%) 0/373 5 0% 1/111 5 0.9% 0.23
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statistical significance, the number of compromised flaps
involved with this study was still small (n 5 16 compro-
mised flaps). If the data from both studies are combined,
a clinical flap salvage rate of 70% and implanted Doppler
salvage rate of 92% is seen, with statistical significance
(P < 0.01, Fisher’s exact test). This is without a statisti-
cal increase in the false-positive rate, with Kind et al.
showing a false-positive rate of 3% compared with our
0.9%. This combined result demonstrates a clear clinical
benefit of the implanted Doppler probe, especially if the
number needed to treat (NNT) before a single additional
flap is salvaged at reexploration is calculated based on
this combined data. With an absolute salvage rate
increase of 22%, the NNT is 4.54, demonstrating that on
average, for every five flaps reexplored for pedicle com-
promise, one additional flap will be salvaged.
The implanted Doppler probe has several other bene-
fits over most other monitoring techniques. It can be used
continuously, allowing for very early recognition of pedi-
cle compromise. It is also a direct pedicle monitor rather
than many other methods, which measure perfusion, oxy-
genation, or ischaemia within the flap itself which take
time to manifest. This removes the possibility of the
Doppler probe being confounded by problems affecting
only part of the flap (territorial problems). Other advan-
tages that the implanted Doppler has over clinical moni-
toring specifically are the monitoring of buried flaps, as
well as improving patient comfort.
These benefits need to be evaluated in the context of
the increased financial cost associated with the implant-
able Doppler probe. The Cook-Swartz implantable Dop-
pler system itself costs US$3000 (reusable) and the dis-
posable probes cost US$250 per patient. During the
course of the current study (121 cases), this was a cost of
US$275 per patient to use the device. In our study, the
overall survival rate was 96%, and thus despite an
increase in flap salvage from 66 to 80%, the overall ben-
efit needs to be assessed with some perspective. Using
our results, the use of the implantable Doppler probe in
the clinically monitored cohort would have potentiated
the salvage of 7.4 additional flaps. The financial cost of
monitoring in the implantable Doppler arm was thus
US$33,275 to potentiate the salvage of an additional 1.4
flaps (in the order of US$20,000 to salvage one flap).
The cost of the surgical management of a failed flap
(both the early management and the repeat reconstruc-
tion) can be well over this amount.
The improved flap salvage rates associated with a
monitoring technique need to be evaluated simultaneously
with the detrimental effects associated with any monitor-
ing technique, in particular, the false-positive takebacks
to theater, the rate of which has been shown to be
extremely low with clinical monitoring.22 Initial studies
of the implanted Doppler probe demonstrated a high
false-positive rate, which in some cases was as high as
37%.23 However, subsequent studies, including that of
Kind et al. have shown rates of around 3%.10,13 It is
thought that the false-positive rates shown in earlier stud-
ies were most likely due to the learning curve associated
with using the device.13,19,20 In keeping with the theory
that a learning curve was responsible for the initial prob-
lems with false-positive rates, our study has demonstrated
the lowest false-positive rate in a case series to date, with
only 1 case in our series of 121 flaps having a false-posi-
tive result. Other described complications with the Dop-
pler probe include failure to apply the probe adequately
and difficulty in probe removal, complications we did not
encounter in any of our cases.
Another way to measure monitoring success would be
to evaluate the performance of the monitor in terms of
false-negative results. However, as discussed, false nega-
tives may depend on an individual surgeon’s decision
making and is thus not a truly independent test of a spe-
cific monitor; i.e., if a flap is ultimately failing due to
pedicle compromise (and not salvaged), the decision to
take a flap back to theater for revision would classify the
flap as a true positive, while not taking it back would
register a false negative. Regardless, as can be seen from
our results, clinical monitoring has been overwhelmingly
successful in this regard, meaning that the false-negative
rate can only be used as a measure of whether the pro-
spective technique can be used as a stand-alone method
or whether it is confined to use in an adjunctive role
only.
In addition to the similar salvage rates as those
attained through the use of clinical monitoring, this study
demonstrates that the Doppler probe has extremely low
false-positive and false-negative rates when used as a
stand-alone device by experienced surgical units. This
means that the use of the implanted Doppler probe can
be accepted as a safe stand-alone monitoring technique
once the initial learning curve of using this technique has
been overcome. Even by the most pessimistic analysis,
this implanted Doppler monitoring performs no worse
than clinical monitoring alone and is likely to be able to
improve flap salvage rates, a conclusion that becomes
apparent when the results of this study are considered in
the context of the previous study by Kind et al. Given
the NNT described earlier, the beneficial effects of this
monitoring technique will be apparent after only a small
number flaps are reexplored due to vascular compromise.
CONCLUSION
The implanted Doppler probe is a safe and an effec-
tive monitoring technique that is able to be used as a
stand-alone monitoring technique. Initial use of the
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device can be associated with a learning curve that may
result in a small number of false-positive results.
Although this study did not show clinical significance, a
trend of significant benefit was seen. Combined with the
results of the previous study by Kind et al., a statistically
significant benefit is in fact confirmed.
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